News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,373 Results
Type
Article (14194)
Company Profile (283)
Press Release (251896)
Section
Business (79560)
Career Advice (154)
Deals (13232)
Drug Delivery (35)
Drug Development (50444)
Employer Resources (31)
FDA (5717)
Job Trends (5150)
News (144469)
Policy (10037)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (912)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21647)
ALS (59)
Alzheimer's disease (820)
Antibody-drug conjugate (ADC) (82)
Approvals (5726)
Artificial intelligence (104)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4582)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (42)
Brain cancer (19)
Breast cancer (138)
Cancer (1237)
Cardiovascular disease (100)
Career advice (133)
Career pathing (2)
CAR-T (107)
Cell therapy (302)
Cervical cancer (6)
Clinical research (40818)
Collaboration (491)
Compensation (216)
Complete response letters (13)
COVID-19 (1031)
CRISPR (36)
C-suite (137)
Cystic fibrosis (75)
Data (1287)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1313)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (77)
Earnings (29569)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48062)
Executive appointments (396)
FDA (6315)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (457)
Gene editing (86)
Generative AI (9)
Gene therapy (224)
GLP-1 (350)
Government (1075)
Grass and pollen (2)
Guidances (18)
Healthcare (6597)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1089)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (17)
Intellectual property (54)
Interviews (17)
IPO (7263)
IRA (11)
Job creations (861)
Job search strategy (128)
Kidney cancer (6)
Labor market (4)
Layoffs (199)
Leadership (2)
Legal (1387)
Liver cancer (30)
Lung cancer (176)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (114)
MASH (46)
Medical device (2592)
Medtech (2593)
Mergers & acquisitions (6251)
Metabolic disorders (356)
Multiple sclerosis (50)
NASH (13)
Neurodegenerative disease (55)
Neuropsychiatric disorders (23)
Neuroscience (1178)
NextGen: Class of 2025 (2019)
Non-profit (856)
Northern California (1494)
Now hiring (21)
Obesity (183)
Opinion (100)
Ovarian cancer (57)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (102)
Partnered (6)
Patents (105)
Patient recruitment (64)
Peanut (35)
People (25503)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14410)
Phase II (18989)
Phase III (12008)
Pipeline (635)
Podcasts (45)
Policy (34)
Postmarket research (852)
Preclinical (6036)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (267)
Real estate (1417)
Recruiting (12)
Regulatory (8535)
Reports (15)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (89)
Series B (57)
Service/supplier (2)
Sickle cell disease (37)
Southern California (1327)
Special edition (11)
Spinal muscular atrophy (116)
Sponsored (11)
Startups (1976)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11788)
Vaccines (203)
Venture capitalists (28)
Webinars (7)
Weight loss (103)
Women's health (17)
Worklife (2)
Date
Today (75)
Last 7 days (324)
Last 30 days (1654)
Last 365 days (20055)
2025 (4302)
2024 (20568)
2023 (22433)
2022 (26841)
2021 (27831)
2020 (23379)
2019 (16253)
2018 (11763)
2017 (13763)
2016 (11849)
2015 (14368)
2014 (10395)
2013 (7490)
2012 (7534)
2011 (7617)
2010 (7432)
Location
Africa (149)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17200)
Australia (2914)
California (3417)
Canada (1033)
China (308)
Colorado (129)
Connecticut (141)
Delaware (86)
Europe (37000)
Florida (399)
Georgia (104)
Idaho (16)
Illinois (208)
India (7)
Indiana (84)
Iowa (1)
Japan (66)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (438)
Massachusetts (2699)
Michigan (69)
Minnesota (133)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (13)
New Jersey (855)
New Mexico (12)
New York (938)
North Carolina (510)
North Dakota (4)
Northern California (1494)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (649)
Puerto Rico (3)
Rhode Island (14)
South America (209)
South Carolina (4)
Southern California (1327)
Tennessee (26)
Texas (389)
Utah (48)
Virginia (66)
Washington D.C. (28)
Washington State (315)
Wisconsin (13)
266,373 Results for "prelude therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
1 min read
Press Releases
Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025
March 10, 2025
·
13 min read
BioCapital
Prelude Therapeutics to Participate in Upcoming June 2024 Healthcare Conferences
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in two upcoming healthcare conferences in June.
June 3, 2024
·
1 min read
Press Releases
Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
November 27, 2024
·
1 min read
BioCapital
Prelude Therapeutics to Participate in Citizens JMP Life Sciences 2024 Conference
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 and 14.
May 9, 2024
·
1 min read
Press Releases
Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 7, 2024
·
13 min read
Business
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, reported its financial results for the first quarter ended March 31, 2024 and provided an update on recent clinical development pipeline and other corporate developments.
May 7, 2024
·
11 min read
BioCapital
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference - February 29, 2024
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, announced that the Company will participate in the Barclays Global Healthcare Conference in Miami, March 12-14, 2024.
February 29, 2024
·
1 min read
Press Releases
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium
October 9, 2024
·
6 min read
Press Releases
Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
December 11, 2024
·
7 min read
1 of 26,638
Next
